N euraxial and locoregional anesthesia are considered techniques of choice for multiple procedures, [1] [2] [3] [4] and are frequently chosen as an alternative to general anesthesia. In this context, diverse adjuvants are often administrated in conjunction with local anesthetics (LAs). The adjunction of epinephrine to LAs is widely used for BACKGROUND: This systematic review examines the benefit and harm of adding epinephrine to local anesthetics for epidural, intrathecal, or locoregional anesthesia. METHODS: We searched electronic databases to October 2017 for randomized trials comparing any local anesthetic regimen combined with epinephrine, with the same local anesthetic regimen without epinephrine, reporting on duration of analgesia, time to 2 segments regression, or any adverse effects. Trial quality was assessed using the Cochrane risk of bias tool and a random-effects model was used. Trial sequential analyses (TSA) were applied to identify the information size (IS; number of patients needed to reach a definite conclusion) and were set to detect an increase or decrease of effect of 30%-50%, depending on the end point considered. Alpha levels were adjusted (1%) for multiple outcome testing. RESULTS: We identified 70 trials (3644 patients, 17 countries, from 1970 to 2017). Median number of patients per trial was 44 (range, 9-174). Thirty-seven trials (1781 patients) tested epinephrine for epidural, 27 (1660) for intrathecal, and 6 (203) for locoregional anesthesia (sciatic, femoral, popliteal, axillary blocks). TSA enabled us to conclude that adding epinephrine to epidural local anesthetics could not decrease postoperative pain intensity by 30%, and did not impact the risk of intraoperative arterial hypotension. IS was insufficient to conclude on the impact of epinephrine on the risk of motor block (IS, 4%), arterial hypotension (20%), urinary retention (23%), or pain intensity at rest (27%) during labor. TSA confirmed that adding epinephrine to intrathecal local anesthetics increased the duration of motor block (weighted mean difference [WMD] 64 minutes; 99% CI, 37-91), analgesia (WMD 34 minutes; 99% CI, 6-62), and the time to 2 segments regression (WMD 20 minutes; 99% CI, (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . IS was insufficient to conclude on its impact on arterial hypotension (IS, 15%), or when administrated in a combined spinal-epidural, on motor block (IS, 11%) or arterial hypotension (IS, 11%). Adding epinephrine to local anesthetics for a locoregional block increased the duration of analgesia (WMD 66 minutes; 98% CI, 32-100]). CONCLUSIONS: Adding epinephrine to intrathecal or locoregional local anesthetics prolongs analgesia and motor block by no more than 60 minutes. The impact of adding epinephrine to epidural local anesthetics or to a combined spinal-epidural remains uncertain.
these regional techniques and is thought to prolong anesthesia via a vasoconstrictive effect delaying LA clearance from the injection site, 5, 6 and via α 2 -adrenoreceptors located in the spinal cord dorsal horn. 7 The benefits and the incidence of adverse effects associated with the use of epinephrine are not clearly defined. A systematic review of randomized controlled trials (RCTs) investigating epidural epinephrine in various settings, but excluding labor, did not include sufficient data to reach valid conclusions. 8 Intrathecal epinephrine was studied in a metaanalysis that included trials that tested epinephrine added to LAs or to opioids, making the results difficult to interpret. 9 In the present analysis, we assessed the impact of adding epinephrine to a LA for epidural, intrathecal, or locoregional anesthesia. Any perineural or plexus LA administration was classified as locoregional anesthesia. We aimed to check whether adding epinephrine resulted in any clinically relevant beneficial or harmful effect. Moreover, we aimed to identify, using trial sequential analysis (TSA), whether additional trials, in these different settings, were still needed.
METHODS

Protocol and Registration
The protocol of this meta-analysis was registered in PROSPERO (CRD: 42015026148). Changes to the protocol are notified in the section "Data items." We followed the Preferred Reporting Items for Systematic Reviews and Metaanalyses (PRISMA) recommendations for data reporting. 10 
Inclusion Criteria
We included RCTs comparing any regimen of any LA with epinephrine (experimental intervention) with the same LA regimen but without epinephrine (control intervention).
Trials were considered if they tested perineural or plexus blocks, or intrathecal or epidural anesthesia in adults (≥18 years) undergoing any surgery, or in parturients during labor. When an additional adjuvant to the LA was used (eg, opioids or clonidine), the trial was included as long as the adjuvant was used in a strictly controlled manner (ie, administration of the same regimen of the adjuvant in both experimental and control groups). For eligibility, a study had to report on at least one of the following outcomes: duration of analgesia (defined as the time in minutes from injection to first request of analgesia), time from injection to 2 segments regression (for intrathecal anesthesia), need for supplementary LA or systemic rescue analgesia, or incidence of any adverse effects.
Noninclusion Criteria
We did not consider trials reporting on digital nerve blocks, blocks for dentistry, LA infiltration (for instance, subcutaneously) or if epinephrine was added to a regional anesthesia regimen in the absence of an LA. Furthermore, we did not consider studies published as abstracts only.
Information Sources and Searches
Databases (MEDLINE, CENTRAL, EMBASE, GOOGLE SCHOLAR) were searched using a high-sensitivity and low-specificity search strategy. The key words "epidural," "peridural," "extradural," "spinal," "intrathecal," "block," "epinephrine," "adrenaline," "analgesia," and "anesthesia" were combined using the Boolean meanings of "AND" and "OR." The last electronic search was performed in October 2016. We also searched trial registries in November 2017 to identify potentially eligible trials. Bibliographies of retrieved articles were checked for additional references. No language restriction was applied (Supplemental Digital Content, Search Strategy, http://links.lww.com/AA/C359).
Study Selection
Studies were selected independently by 2 authors (C.T., M.Z.). One (C.T.) screened all references based on titles and abstracts and excluded references that obviously did not adhere to our inclusion criteria. Criteria for inclusion and noninclusion were checked by a further author (A.S.). Full reports were screened for final inclusion by 2 authors (C.T., A.S.).
Data-Collecting Process
One author (C.T.) extracted all relevant information from the original reports. Another author (A.S.) checked all extracted data. Discrepancies were resolved through discussion with an additional author (N.E.). Authors of included studies were contacted to obtain supplemental relevant information; for instance, we asked them for exact values of means and standard deviations (SDs) that were reported in graphs only, or for data reported as medians with ranges, or for unpublished outcomes. If contacting the authors was unsuccessful, we extracted the data from the graphs, and extrapolated means and SD from the published medians and ranges. 11 
Data Items
We extracted information on journal name, year of publication, first author's name, type of surgery and anesthetic procedures, number of randomized, excluded, and eventually analyzed patients, type and regimen of the LA, and regimen of epinephrine and of other adjuvants.
Predefined primary outcomes for the assessment of the impact of adding epinephrine to LAs were duration of analgesia, time to 2 segments regression (for intrathecal anesthesia), total consumption of LAs, and adverse effects. While going through the studies, we realized that some of our predefined outcomes were not relevant for all types of regional anesthesia. For instance, duration of analgesia is less an issue when analgesia is performed with an epidural catheter since reinjection of the anesthetic drug is possible. To focus on clinically relevant outcomes, we redefined outcomes of primary interest according to anesthesia techniques and settings (Table 1) . For instance, we assumed that the adjunction of epinephrine to epidural LAs was useful only if it decreased the incidence of arterial hypotension or urinary retention or if it prolonged the duration of postoperative analgesia. Similarly, we assumed that the adjunction of epinephrine to LAs for a plexus block was useful only if it prolonged analgesia without prolonging motor block. All other outcomes that were reported in the original studies were extracted and considered as secondary outcomes.
Risk of Bias in Individual Studies
We assessed the quality of individual trials using the Cochrane risk of bias tool which contains 6 items rated as www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA E META-ANALYSIS low, high, or unclear risk of bias. 12 Because small trials tend to overestimate treatment effects, study size was included under the criterion "other bias." For the purpose of this analysis, we arbitrarily defined a study size <50 patients as a high risk of bias. Quality assessment was done by 1 author (C.T.) and checked by another author (A.S.). Discrepancies were discussed with a third author (N.E.).
Statistical Analyses
All analyses were stratified according to the 3 routes of epinephrine administration (epidural, intrathecal, locoregional), and subgroups were computed within each stratum according to the different clinical settings (labor, perioperative, postoperative) to provide information that is clinically relevant.
There was an arbitrary pre hoc decision to analyze data only when they were reported in at least 3 studies or 100 patients. For continuous outcomes, we extracted means and SDs for experimental and control groups, as reported in the original trials. Mean differences with 95% CIs were then computed for each study separately and a pooled estimate of mean differences was computed as a weighted mean difference (WMD) using the inverse variance method for the calculation of the weights of the different studies. For binary outcomes, we extracted the cumulative number of events reported in the experimental and control groups separately and computed an estimation of the effect of the intervention on the outcome using relative risks (RRs) and 95% CIs. The Mantel-Haenszel method was then used to pool all the RRs across studies. There was a pre hoc decision to use a random-effects model for all analyses because the impact of adding epinephrine to an LA may differ according to different study settings. In case of statistical evidence of heterogeneity (P value for the test of heterogeneity <.1), we intended to perform sensitivity analyses to search for the sources of heterogeneity.
For studies that compared different doses of epinephrine added to a single LA regimen, we checked whether the different doses resulted in statistically significant differences in outcomes. When the data were homogeneous (P value for the test of heterogeneity >.1), we pooled them. If not (P < .1), we selected the dose that was closest to the doses examined in the other trials.
We adapted the α levels of our analyses to account for multiple outcome testing within each of the 3 routes of epinephrine administration (epidural, intrathecal, locoregional), taking into account the subgroup analyses performed for the different clinical settings (labor, perioperative, postoperative) based on the pragmatic recommendations by Jakobsen et al, 13 which suggest dividing the standard 0.05 with the value situated halfway between 1 (no adjustment) and the number of primary outcomes compared (Bonferroni adjustment). For all primary outcomes, related to the epidural administration of epinephrine, this resulted in an α level of .01 and a 99% CI around the pooled point estimates (4 outcomes, 9 subgroups (0.05/[{9 + 1}/2]) = 0.01) instead of the conventional 0.05 and 95% CI. Similarly, the α level was set at .01 for all primary outcomes related to the intrathecal administration of epinephrine (6 outcomes, 7 subgroup analyses), and at .02 for those related to intrablock administration of epinephrine (3 outcomes, no subgroup analyses). For secondary outcomes, all α levels were set at .01.
Meta-analyses were performed using RevMan version 5.3.5 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark), STATA 15 (StataCorp, College Station, TX), and Microsoft Excel version 12.3.6 for Mac (Microsoft, Redmond, WA). For all outcomes of primary interest, we used funnel plots to visually assess the risk of publication bias. We additionally performed TSA (Trial Sequential Analysis, version 0.9.5.5 beta; Copenhagen Trial Unit, Copenhagen, Denmark, 2016), to add information regarding the number of patients required to reach a definite conclusion, considering a power of 80%, an α level of 1% (or 2% for locoregional anesthesia), and a 2-sided test.
14 For all TSA analyses, we assumed that adding epinephrine to an LA would be considered clinically relevant if it changed the outcome by 30%-50% depending on the end point. Details of assumptions tested are provided in Supplemental Digital Content, Table A , http://links.lww.com/AA/C359.
RESULTS
Selection of Trials
We retrieved 183 potentially relevant trial reports of which 70 underwent further analyses ( Figure) .
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Trial Characteristics
The 70 trials were published between 1970 and 2017 and included data on 3644 patients (Supplemental Digital Content, Table B , http://links.lww.com/AA/C359). They originated from 17 countries: United States (28 trials); United Kingdom (8); France (5); Belgium and Japan (4 each); Turkey and Finland (3 each); China, India, Korea, the Netherlands, and Sweden (2 each); and Canada, Ireland, Republic of Macedonia, Switzerland, and Taiwan (1 each). All reports were published in English except 2 that were published in French. 57, 67 Median number of patients per trial was 44 (range, 9-174). In 37 trials (1781 patients), epinephrine was added to epidural LAs. In 12 of those, regimens were administered continuously through a catheter. In 27 trials (1660 patients), epinephrine was added to intrathecal LAs; of those, 8 were using a combined spinal-epidural (CSE) technique. Finally, in 6 trials (203 patients), epinephrine was added to an LA for locoregional anesthesia (sciatic, femoral, popliteal, axillary).
LAs used were bupivacaine (40 trials), lidocaine (10), ropivacaine (9), tetracaine (6), chloroprocaine (3), levobupivacaine (2), and lidocaine CO 2 or mepivacaine (1 trial each; numbers do not add up because 2 trials were using 2 different LAs). Further adjuvants were used in 29 trials and included fentanyl (18 trials), sufentanil (6), morphine (3), and butorphanol or clonidine (1 trial each).
Studies were performed in a variety of settings: labor (24 trials), cesarean delivery (15), orthopedic (13), urologic (6), general (4), gynecologic (3), lumbar spine (2), or vascular surgery (1). In 2 trials, patients underwent a variety of surgical interventions. 47, 79 In 4 trials, general anesthesia was systematically administrated in combination with regional anesthesia, 69, 72, 76, 80 and in 5 trials, general anesthesia was used as a rescue in case of failed regional anesthesia. 20, 22, 25, 35, 58 Definitions of the end points varied among original studies. We used the definitions as reported in the trials (Supplemental Digital Content, Table C We contacted the authors of 41 articles and asked for additional data; the authors of 14 articles responded and additional unpublished data from 3 trials could eventually be added to our analyses. 39, 40, 71 
Epidural Epinephrine
We found no evidence that adding epinephrine to an epidural LA changed any of the primary outcomes. Sample sizes were either too small to reach a definite conclusion (motor block, urinary retention) or sufficient to conclude on the futility of this adjunction (hypotension, pain intensity; Table 2 , Supplemental Digital Content, Table A and Figures  B1-B4 , http://links.lww.com/AA/C359). Similarly, we found no evidence of an impact of epinephrine administration on any of the secondary outcomes ( Table 3) .
The impact of epidural epinephrine according to the different clinical settings is described in the following 3 paragraphs.
Labor
Analgesia. Seventeen trials (886 patients) tested epinephrine added to epidural LAs for labor analgesia. Regimens were administrated as boluses in 11 trials, [15] [16] [17] [18] 36, 37, 44, 45, 56, 73, 82 and via a continuous infusion in 6 trials. 32, 33, 52, 54, 62, 64 LAs were bupivacaine (13 trials), and chloroprocaine, levobupivacaine, lidocaine, or ropivacaine (1 trial each). Concentrations of epinephrine ranged from 1 to 5 µg·mL . The required sample sizes were not reached to definitely conclude on the impact of epinephrine on the duration of motor block: information size (IS) (4%), arterial hypotension (20%), urinary retention (23%), or pain intensity at rest (27%). There were too few trials to assess graphical evidence of publication bias ( Table 2 , Supplemental Digital Content, Table A and Figures B1-2 , B2-2, B3-1, and B4-2, http://links.lww.com/AA/C359). We found no evidence of an impact of epinephrine on the incidences of ephedrine requirement, postoperative nausea and vomiting (PONV), pruritus, sedation, Apgar <7 at 1 minute, umbilical arterial pH, the need for cesarean delivery, or for instrumentation for delivery ( 76 LAs were bupivacaine (9 trials), lidocaine or ropivacaine (2 each), and chloroprocaine or levobupivacaine (1 each). Concentrations of epinephrine ranged from 2.5 to 5 µg·mL −1
. The addition of epinephrine to epidural LAs showed no impact on the risk of intraoperative arterial hypotension. Although IS was not reached (50%), the limits of futility were crossed suggesting that further trials were unlikely to demonstrate a change of 20% on this outcome (Table 2 , Supplemental Digital Content, Table A and Figures  B2-3 , http://links.lww.com/AA/C359). There was no evidence either that epidural epinephrine had an impact on the risks of ephedrine requirement, bradycardia, or PONV, or on umbilical arterial pH (Table 3) .
Postoperative Analgesia. Five trials (290 patients) tested epinephrine added to a postoperative infusion of epidural LAs. Among them, 3 used a fixed infusion rate 39, 40, 69 and 2 used a fixed infusion rate in addition to patient-controlled epidural analgesia. 29, 30 LAs were bupivacaine (3 trials) and ropivacaine (2 trials). Concentrations of epinephrine ranged from 0.5 to 5 µg·mL . There was insufficient evidence to definitely conclude on the impact of epinephrine on motor block (IS, 31%). There were too few trials to test for publication bias. There was sufficient evidence to conclude that epinephrine did not decrease pain intensity at rest by >30% (Table 2 , Supplemental Digital Content, Table A and Figures B4-3 , http://links.lww.com/AA/C359). Incidences of PONV, pruritus, and sedation were not impacted by epinephrine (Table 3) .
Intrathecal Epinephrine
We found evidence that adding epinephrine to an intrathecal LA significantly prolonged the duration of analgesia, motor block, and time to 2 segments regression. Its impact on the risk of hypotension and on the proportion of motor block when administrated in a CSE regimen remained unclear due to insufficient sample size ( Table 2 , Supplemental Digital Content, Table A and Figures B5-B9, http://links.lww.com/AA/C359). Similarly, we found no evidence of any impact of epinephrine on any of the secondary outcomes (Table 3 ). The impact of intrathecal epinephrine, according to the different clinical settings, is described in the following 2 paragraphs.
Surgical Anesthesia. Twenty-one studies (1289 patients) examined the effect of epinephrine added to intrathecal LAs for surgical procedures. 19, 20, 22, 25, 27, 28, 31, 43, 47, 48, 51, 55, 59, 60, [66] [67] [68] 75, 77, 83, 84 Two of those were using a CSE technique. 48, 68 From these trials, we extracted the end points duration of analgesia and time to highest sensory block before the first epidural injection. LAs were bupivacaine (9 trials), tetracaine and lidocaine (5 each), and chloroprocaine (1). In 1 trial, both bupivacaine and tetracaine were tested. 60 Doses of epinephrine ranged from 15 to 500 µg. Intrathecal epinephrine significantly increased the duration of analgesia (WMD 34 minutes [99% CI, 5.9-62]; P = .002), the duration of motor block (64 minutes ; P > .001), and the time to 2 segments regression (20 minutes [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] ; P < .001). The IS required was reached for the time to 2 segments regression. Although it was not reached for duration of analgesia and of motor block, the limits of the α spending boundaries Abbreviations: CI, confidence interval; CSE, combined spinal-epidural; n, number of events; P1, P value of the overall effect; P2, P value of heterogeneity of the data; P3, P value of heterogeneity between clinical settings; PONV, postoperative nausea and vomiting; RR, relative risk; tot, total number of patients per group; WMD, weighted mean difference. (Table 2 , Supplemental Digital Content, Table  A and Figures B6-B8 , http://links.lww.com/AA/C359). The impact of intrathecal epinephrine on the incidence of hypotension remained unclear due to insufficient sample size ( Table 2 , Supplemental Digital Content, Table A and Figure B5 -2, http://links.lww.com/AA/C359). In addition, the incidences of bradycardia, ephedrine requirement, PONV, and pruritus; the time to reach the highest sensory block; and pain intensity at rest were analyzed. Intrathecal epinephrine increased the time to reach the highest sensory block (1.4 minutes [99% CI, 0.2-2.9]; P < .001). There was no evidence of an impact of adding epinephrine on the other end points (Table 3) .
Combined Spinal-Epidural for Labor Analgesia. Six trials (371 patients) tested epinephrine added to intrathecal LAs for labor analgesia using the CSE technique. 24, 41, 42, 46, 63, 78 LAs were bupivacaine (5 trials) and ropivacaine (1) . Doses of epinephrine ranged from 2.25 to 200 µg. There were not enough data to definitely conclude on the impact of epinephrine on motor block (IS, 11%) or on arterial hypotension (11%) ( Table 2 , Supplemental Digital Content, Table A and Figures B5-3 and B9, http://links.lww.com/ AA/C359). Incidences of ephedrine requirement, PONV, pruritus, need for cesarean delivery or instrumentation, or the risk of neonatal bradycardia were not impacted by epinephrine (Table 3) .
Locoregional Anesthesia
Six trials (203 patients) tested epinephrine added to an LA for locoregional anesthesia. 35, 57, 70, 71, 74, 80 LAs used were ropivacaine (3 trials), lidocaine (1), and mepivacaine (1). One trial tested both lidocaine and lidocaine CO 2 .
57 Doses of epinephrine ranged from 100 to 300 µg. Epinephrine increased the duration of analgesia (WMD 66 minutes [98% CI, 32-100]); the required IS was reached ( Table 2 , Supplemental Digital Content, Table A and Figure B10 , http://links.lww. com/AA/C359). Incidence of block failure was reported in 4 trials; we found no evidence that it was influenced by epinephrine (Table 3) . 35, 70, 71, 80 Two studies reported on the duration of motor block; they both suggested that epinephrine prolonged the motor block, but there were not enough patients to allow for data computation. 35, 74 Sensitivity Analyses Significant heterogeneity was found for some of the primary outcomes.
Epidural for Labor Analgesia. The degree of heterogeneity could be decreased for the outcome arterial hypotension by regrouping the trials using bupivacaine (P for heterogeneity = .12); this did not change our estimate significantly (RR of this subgroup changed from 0. Intrathecal Anesthesia for Surgery. The degree of heterogeneity could be decreased by regrouping trials according to the LA used for the outcome duration of analgesia. This did not change our estimates.
For all other primary outcomes, the number of trials or patients per stratum were insufficient to perform sensitivity analyses.
DISCUSSION
Summary of Findings
We assessed the impact of adding epinephrine to an LA for regional anesthesia. We were able to conclude that adding epinephrine to epidural LAs did not decrease postoperative pain intensity by at least 30%, and did not impact the risk of intraoperative arterial hypotension. Also, adding epinephrine to intrathecal LAs increased the duration of motor block by about 60 minutes, of analgesia by about 30 minutes, and the time to 2 segments regression by 20 minutes. Adding epinephrine to LAs for a locoregional block significantly increased the duration of analgesia by about 60 minutes. Other important results of this systematic review were to identify the knowledge gaps. The IS, thus the number of patients needed to reach a definite conclusion, was insufficient to conclude on the impact of epinephrine on a variety of end points, for instance, on motor block when administrated through an epidural catheter, or on the risk of arterial hypotension when administrated intrathecally.
What Is Already Known on This Subject?
The role of epinephrine adjunction has been addressed in 2 systematic reviews. 8, 9 One, examining the impact of adding epinephrine to epidural LAs in 7 trials (257 patients), 8 was inconclusive due to the limited number of trials. The second, including 24 trials (1271 patients), addressed the role of epinephrine added to intrathecal LAs. 9 Similar to our findings, the authors concluded that intrathecal epinephrine prolonged the duration of analgesia and motor block as well as the time to 2 segments regression and to reach the highest sensory block. In contrast to our findings, they also found that intrathecal epinephrine increased the incidence of arterial hypotension and PONV, especially with doses ≤100 µg.
What Does This New Analysis Add?
Our systematic review included more trials than previously published ones. 8, 9 We were able to investigate the impact of epinephrine added to LAs in various settings, such as labor, surgery, or postoperative analgesia. We included TSA to estimate the number of patients needed to reach definite conclusions on benefit and harm, and we adapted α levels to adjust for multiple outcomes testing. Interestingly, for most outcomes, the available IS was still too small to allow for reliable conclusions to be drawn. Finally, our analyses are the first to evaluate the adjunction of epinephrine to locoregional anesthesia. 86 When added to an LA used for a sciatic, femoral, popliteal, or axillary block, epinephrine is likely to increase the duration of postoperative analgesia by about 1 hour.
Weaknesses of Our Analysis
This systematic review has several limitations; most are due to weaknesses of the original studies. First, the majority of the trials included <50 patients, bearing the risk to report exaggerated beneficial effects. 87 Second, many outcomes were not standardized. This may be due to the lack of a common, clearly defined research agenda. Third, we combined outcomes that were not necessarily the primary outcomes in the included trials. Although this may have added heterogeneity to our analyses, it also increased their power and generalizability. Fourth, a large variety of LA regimens were used with www.anesthesia-analgesia.org ANESTHESIA & ANALGESIA E META-ANALYSIS different vasoconstrictive properties which may influence their pharmacokinetics. 88 Fifth, although epinephrine doses varied across trials, we were unable to establish dose-responsiveness. Finally, although we have adapted the α levels of statistical significance to adjust for multiple testing, there is yet no consensus on which method of adjustment should be used, and some may not agree with our pragmatic method. Similarly, for the purpose of clarity, we have maintained the adjusted α levels to perform TSA. The number of missing patients to achieve definite conclusions may therefore be overestimated.
Clinical Implications
Epinephrine has been used for many years as an adjuvant to LAs with the aim to prolong sensory nerve blockade and delay systemic uptake of the LA, thereby reducing the risk of anesthetic toxicity. This systematic review suggests that the duration of analgesia is likely to be prolonged by about 30 minutes when epinephrine is added to intrathecal LAs and by about 60 minutes when added to locoregional LAs. This degree of efficacy must be put into its clinical context. Adding clonidine to intermediate or long-acting LAs for a single-shot peripheral nerve or plexus block prolongs duration of analgesia by about 120 minutes, 89 and to intrathecal LAs, by about 100 minutes. 90 Opioids added to LAs prolong the duration of postoperative analgesia even more, that is, by 120 minutes with the short-acting fentanyl, and by more than 8 hours with morphine. 91 Also, adding dexamethasone or dexmedetomidine to LAs was shown to prolong duration of analgesia by about 4 and 7 hours, respectively. 85, 92 These data suggest that there are more powerful alternatives than epinephrine to prolong analgesia. The question remains, whether epinephrine as an adjuvant reduces the risk of systemic LA toxicity. However, unless the LA is injected in very high doses, for instance, through multiple subcutaneous infiltrations, the risk of systemic LA toxicity may be negligible.
Research Agenda
TSA suggested that further trials on epinephrine added to intrathecal LAs are probably not needed because its impact seems well characterized. However, in the context of labor analgesia, when epinephrine is added to an intrathecal or epidural LA, the available evidence is still not sufficient to conclude on its impact on motor block, on arterial hypotension, or on the need for instrumentation or cesarean delivery. Also, well-designed RCTs are necessary to better characterize the impact of epinephrine added to an LA in an epidural catheter for both labor and postoperative analgesia. Finally, dose-responsiveness and the adequate dose of epinephrine that needs to be administrated still need to be defined.
CONCLUSIONS
Adding epinephrine to intrathecal or locoregional LAs prolongs analgesia and motor block by 30-60 minutes. The impact of adding epinephrine to epidural LAs or to a CSE remains uncertain. E
